Literature DB >> 10775058

Acute tubulointerstitial nephritis following intravenous immunoglobulin therapy in a male infant with minimal-change nephrotic syndrome.

H Tanaka1, S Waga, T Tateyama, K Sugimoto, Y Kakizaki, M Yokoyama.   

Abstract

A boy aged 4 years with nephrotic syndrome (NS) was referred to our hospital because of the third relapse of NS. Hypogammaglobulinemia associated with massive proteinuria was observed at the presentation. Residual urinary tract infection required intravenous piperacillin and immunoglobulin therapy (IVIG). Soon after IVIG, he complained of high fever with chills, bilateral knee joint pain, dry cough and chest discomfort. Although he did not develop renal insufficiency, a transient increase in the urinary beta2-microglobulin and decrease in the serum complement hemolytic activity were observed. These clinical manifestations spontaneously ceased. A percutaneous renal biopsy for his NS performed 19 days after the episode of allergic reaction revealed tubulointerstitial nephritis (TIN) with marked eosinophil infiltrates. Glomeruli showed minor glomerular abnormalities. Renal complications associated with IVIG treatment have been reported to date, however, acute TIN has rarely been seen.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10775058     DOI: 10.1620/tjem.189.155

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  3 in total

Review 1.  Acute tubulointerstitial nephritis.

Authors:  Tim Ulinski; Anne-Laure Sellier-Leclerc; Elena Tudorache; Albert Bensman; Bilal Aoun
Journal:  Pediatr Nephrol       Date:  2011-06-03       Impact factor: 3.651

Review 2.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

3.  Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia.

Authors:  Keisuke Sugimoto; Hitomi Nishi; Tomoki Miyazawa; Norihisa Wada; Akane Izu; Takuji Enya; Mitsuru Okada; Tsukasa Takemura
Journal:  BMC Nephrol       Date:  2014-07-08       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.